argenx
The Director, US Patient Assistance Program leads the strategy, design, and execution of argenx's patient access initiatives for current and future indications. This role involves shaping scalable operational models, managing vendor performance, and ensuring compliance while partnering with cross-functional teams to improve patient support pathways for autoimmune therapies.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
307% above the average for this role
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Senior Director, Pricing Strategy - Immunology
Regeneron Pharmaceuticals
Director of Patient Services
Aquestive Therapeutics
Lead, US Hematology Pipeline Commercialization
sanofi us
Patient Access Specialist
AstraZeneca
Senior Director, US Market Access Strategy, Povetacicept (POVE)
Vertex
Regional Patient Access Manager
Neurocrine Biosciences